Trial · NCT02607293
A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
NCT02607293, Completed, Merck KGaA, Darmstadt, Germany
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation. Trials, record NCT02607293. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02607293
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
- NCT number
- NCT02607293
- Status
- Completed
- Enrollment
- 1,064 participants, actual
- Lead sponsor
- Merck KGaA, Darmstadt, Germany
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Gonal-f®, Long GnRH agonist, GnRH antagonist
- First posted
- 2015-11-18
- Last updated
- 2018-06-28
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of subjects with polycystic ovary | Baseline | |
| Primary | Serum Testosterone levels | Baseline | |
| Primary | Number of subjects with history of menstrual disorders | Baseline | |
| Primary | Number of subjects with hirsutism | Baseline | |
| Primary | Number of oocytes retrieved | Baseline up to 2-7 days until end of stimulation cycle (approximately 28 days) | |
| Secondary | Total Dose of Recombinant Follicle Stimulating Hormone (r-FSH) | Baseline up to 1 month | |
| Secondary | Daily Dose of Recombinant Follicle Stimulating Hormone (r-FSH) | Baseline up to 1 month | |
| Secondary | Number of Metaphase II (M II) oocyte retrieved | Baseline up to 2-7 days until end of stimulation cycle (approximately 28 days) | |
| Secondary | Biochemical pregnancy rate | 4 to 6 Weeks after Embryo transfer (Up to 4 months) | Biochemical pregnancy was defined as a positive pregnancy test (serum beta-hCG test) of the post-treatment assessment period |
| Secondary | Clinical pregnancy rate | 4 to 6 Weeks after Embryo transfer (Up to 4 months) | Clinical pregnancy was defined as existence of at least one ultrasonography confirmed gestational sac in the uterus, with or without heartbeat. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02607293
GET https://conductscience.org/api/trials/v1/NCT02607293/registered